PDF herunterladen
J Pediatr Intensive Care 2020; 09(03): 210-212
DOI: 10.1055/s-0039-1700964
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Pediatric Shock: An Uncommon and Underrecognized Etiology

Kim R. Derespina
1   Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States
,
Shubhi Kaushik 
1   Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States
,
Shivanand S. Medar 
1   Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

18. Oktober 2019

27. November 2019

Publikationsdatum:
10. Januar 2020 (online)

    Lizenzen und Reprints

Abstract

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a well-known disease entity. Kawasaki shock syndrome (KSS), on the other hand, is less well recognized and has been reported in small single-center international studies and case reports. We report a case in the United States of an 11-year-old male with multiorgan failure and shock, presumed to be secondary to toxic shock but later diagnosed with KSS, an underrecognized entity in the US and review the literature. KSS should be considered in a critically ill child with unexplained shock.

Keywords

Kawasaki disease - Kawasaki shock syndrome - erythema
 

  • References

  • 1 Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16 (03) 178-222
    PubMedGoogle Scholar
  • 2 McCrindle BW, Rowley AH, Newburger JW. , et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135 (17) e927-e999
    PubMedGoogle Scholar
  • 3 Kanegaye JT, Wilder MS, Molkara D. , et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123 (05) e783-e789
    CrossrefPubMedGoogle Scholar
  • 4 Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr 2013; 172 (03) 337-342
    CrossrefPubMedGoogle Scholar
  • 5 Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 2008; 122 (04) e786-e790
    CrossrefPubMedGoogle Scholar
  • 6 Taddio A, Rossi ED, Monasta L. , et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol 2017; 36 (01) 223-228
    CrossrefPubMedGoogle Scholar
  • 7 Kuo CC, Lee YS, Lin MR. , et al. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital. J Microbiol Immunol Infect 2018; 51 (02) 184-190
    CrossrefPubMedGoogle Scholar
  • 8 Lin MT, Fu CM, Huang SK, Huang SC, Wu MH. Population-based study of Kawasaki disease shock syndrome in Taiwan. Pediatr Infect Dis J 2013; 32 (12) 1384-1386
    CrossrefPubMedGoogle Scholar
  • 9 Ma L, Zhang YY, Yu HG. Clinical manifestations of Kawasaki disease shock syndrome. Clin Pediatr (Phila) 2018; 57 (04) 428-435
    CrossrefPubMedGoogle Scholar
  • 10 Yang HF, Chen WL, Chang CN, Chen SJ, Fan HC. Kawasaki disease shock syndrome: case report. Paediatr Int Child Health 2016; 36 (01) 76-78
    CrossrefPubMedGoogle Scholar
  • 11 Dionne A, Dahdah N. Myocarditis and Kawasaki disease. Int J Rheum Dis 2018; 21 (01) 45-49
    CrossrefPubMedGoogle Scholar
  • 12 Best D, Millar J, Kornilov I. , et al. Extracorporeal membrane oxygenation for Kawasaki disease: two case reports and the Extracorporeal Life Support Organization experience 1999-2015. Perfusion 2017; 32 (07) 609-612
    CrossrefPubMedGoogle Scholar